- 2024,11,05
Academician Yang (fifth from left), Lin Dongyong (third from right), Ye Haifeng (second from right), Chairman Yan (fourth from left), President Zhao (first from right), and other guests took a group photo as souvenirs.
With love for life and health and concern for the development of marine biological medicine industry in his hometown, Yang Huanming, an academician of the CAS Member and a scientist from Wenzhou, accompanied by Lin Dongyong, the former deputy director of the Zhejiang Provincial Bureau of Oceans and Fisheries, Ye Haifeng, director of the Standing Committee of the People's Congress of Dongtou District and other leaders, came to Cheng Yi Pharmaceutical Health Industrial Park for investigation and guidance at 10:00 a.m. on October 19. This is Academician Yang Huanming's third visit to the Sincere Pharmaceutical Industry for inspection and guidance. As soon as he got off the car, Academician Yang enthusiastically took Chairman Yan's hand, took photos with his phone, and happily said, "Your factory has undergone significant changes. Now that it is built so tall, I need to take some photos and take them back to take a look.
Academician Yang visited the company's laboratory.
In April and October 2016, Academician Yang Huanming visited Cheng Yi Pharmaceutical twice for inspection and guidance. In October of that year, when Cheng Yi Pharmaceutical celebrated the 50th anniversary of its founding, Academician Yang was invited to deliver an academic report entitled "Human Genome Project and Pharmaceutical Biology Design" at the "Zhejiang Marine Biological Medicine Forum", and put forward academic viewpoints such as "treasure to the sea", which pointed out the direction for Cheng Yi Pharmaceutical to transform into marine biological medicine.
On April 26, 2016, Academicians Kang Le and Yang Huanming of the Chinese Academy of Sciences came to Cheng Yi Pharmaceutical for investigation and guidance (Figure 1 above);
On October 19, 2016, Academician Yang made an academic report on the Human Genome Project and the Biological Design of Drugs (Figure 2);
On October 19, 2020, Academician Yang (right) happily held Yan Dong's biography "From the Sea to Shanghai" and took a photo with him (Figure 3).
After watching the introduction video of Cheng Yi Pharmaceutical and listening to General Manager Zhao Chunjian's report on the overall ideas of Cheng Yi Pharmaceutical's "14th Five Year Plan (2021-2025)" and the investment project situation of the second phase of the Health Industry Park, Academician Yang Huanming made a comprehensive review one by one. Especially when it comes to choosing the direction of biopharmaceutical development, he suggests that the company can embark on a "genetic engineering" project, which has low pollution, fast investment results, and the current production conditions of Cheng Yi Pharmaceutical are in place. He is very willing to connect Cheng Yi Pharmaceutical's "genetic engineering" project with top international scientists and strive for the project to be implemented as soon as possible.
Academician Yang is carefully listening to General Manager Zhao's report on the company's 14th Five Year Plan for development.